Afficher la notice abrégée

Guide de prise en charge des sequelles respiratoires post infection a SARS-CoV-2. Propositions de prise en charge elaborees par la Societe de Pneumologie de Langue Francaise. Version du 10 novembre 2020.

dc.rights.licenseopenen_US
dc.contributor.authorANDREJAK, C.
dc.contributor.authorCOTTIN, V.
dc.contributor.authorCRESTANI, B.
dc.contributor.authorDEBIEUVRE, D.
dc.contributor.authorGONZALEZ-BERMEJO, J.
dc.contributor.authorMORELOT-PANZINI, C.
dc.contributor.authorSTACH, B.
dc.contributor.authorUZUNHAN, Y.
dc.contributor.authorMAITRE, B.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRAHERISON-SEMJEN, Chantal
dc.date.accessioned2021-03-01T09:40:34Z
dc.date.available2021-03-01T09:40:34Z
dc.date.issued2021-01
dc.identifier.issn1776-2588 (Electronic) 0761-8425 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26370
dc.description.abstractEnThe French-speaking Respiratory Medicine Society (SPLF) proposes a guide for the management of possible respiratory sequelae in patients who have presented with SARS-CoV-2 pneumonia (COVID-19). The proposals are based on known data from previous epidemics, preliminary published data on post COVID-19 follow-up and on expert opinion. The proposals were developed by a group of experts and then submitted, using the Delphi method, to a panel of 22 pulmonologists. Seventeen proposals were validated ranging from additional examinations after the minimum assessment proposed in the SPLF monitoring guide, to inhaled or systemic corticosteroid therapy and antifibrotic agents. These proposals may evolve over time as knowledge accumulates. This guide emphasizes the importance of multidisciplinary discussion.
dc.language.isoFRen_US
dc.titleGuide de prise en charge des sequelles respiratoires post infection a SARS-CoV-2. Propositions de prise en charge elaborees par la Societe de Pneumologie de Langue Francaise. Version du 10 novembre 2020.
dc.title.alternativeRev Mal Respiren_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.rmr.2020.11.009en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33280941en_US
bordeaux.journalRevue des Maladies Respiratoiresen_US
bordeaux.page114-121en_US
bordeaux.volume38en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamEPICENE_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03154652
hal.version1
hal.date.transferred2021-03-01T09:40:38Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.title=Guide%20de%20prise%20en%20charge%20des%20sequelles%20respiratoires%20post%20infection%20a%20SARS-CoV-2.%20Propositions%20de%20prise%20en%20charge%20elaborees%20par%20la%2&rft.atitle=Guide%20de%20prise%20en%20charge%20des%20sequelles%20respiratoires%20post%20infection%20a%20SARS-CoV-2.%20Propositions%20de%20prise%20en%20charge%20elaborees%20par%20la%&rft.jtitle=Revue%20des%20Maladies%20Respiratoires&rft.date=2021-01&rft.volume=38&rft.issue=1&rft.spage=114-121&rft.epage=114-121&rft.eissn=1776-2588%20(Electronic)%200761-8425%20(Linking)&rft.issn=1776-2588%20(Electronic)%200761-8425%20(Linking)&rft.au=ANDREJAK,%20C.&COTTIN,%20V.&CRESTANI,%20B.&DEBIEUVRE,%20D.&GONZALEZ-BERMEJO,%20J.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée